Jefferies on Cabaletta Bio Inc. (CABA): 'we see solid setup from here'

March 27, 2026 10:55 AM

Jefferies analyst Roger Song reiterated a Buy rating and $14.00 price target on Cabaletta Bio Inc. (NASDAQ: CABA)The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found